PFE Pfizer Inc.

neutral track record → $27.11 -0.23 (-0.8%)
Mkt Cap $153B P/E 19.8 fwd 9.6 52wk $21.87 - $28.75 Earnings 2026-04-28 1d ago
Insider buying: $527,312 bought by 10 insiders (30d)
Est. revisions: -1.5% (3 up, 2 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model & Position History (net +0.6)

Factor Model

net +0.6 2.5 / 10
Est. Revisions
-0.1
Insider Activity
+0.5
Momentum
+0.0
Analyst Rev.
+0.4
Narrative Gap
+0.0

BofA Cuts Pfizer Target to $26 Amid Vaccine Debate

Watch: Watch Pfizer's next earnings for pipeline updates post-Phase 3 oncology data to gauge impact beyond vaccine-related noise.

Full analysis

BofA lowered Pfizer's price target to $26 from $27 on April 9, maintaining a Neutral rating amid a complex vaccination landscape. A Belgian court ordered Poland and Romania to pay €1.9 billion for Pfizer Covid-19 vaccines. Elon Musk publicly criticized the Covid-19 vaccine dosage, intensifying debate. Insider buying indicates some confidence with $527K recent purchases. UBS kept a Neutral rating on April 13, reflecting stable but unimpressive outlook.

This reflects cautious investor sentiment balancing legal vaccine payments and public criticism against steady insider support and mixed analyst views, suggesting near-term volatility with no clear growth catalyst.

Evidence

1d ago UBS main PFE: Neutral → Neutral
1d ago Insider buy by BLAYLOCK RONALD E (PFE): $499,072
1d ago Insider buy by GOTTLIEB SCOTT (PFE): $28,240
2d ago Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High' benzinga
2d ago BofA Lowers its Price Target on Pfizer (PFE) to $26 from $27 yahoo-finance
6d ago Jefferies Reiterates Buy Rating on Valneva (VALN) After Phase 3 Data yahoo-finance
10d ago Poland, Romania Ordered to Honor Vaccine Deal with Pfizer yahoo-finance
16d ago Pfizer (PFE) – Among the 15 Large Cap Stocks with Highest Dividends yahoo-finance
7 older signals
17d ago Jim Cramer on Pfizer: “I Just Need to Know Their Product Flow Better”
19d ago Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study of TALZENNA®
20d ago Income Investors Face a Hard Truth About Pfizer’s Payout Safety
21d ago Pfizer Stock Is Doing Something It Hasn't Done Since 2022
23d ago Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now
25d ago Looking for Safety and Yield as Oil Prices Whip Saw? This Stock Has You Covered.
27d ago Jim Cramer Notes Pfizer (PFE) Has “Got a Lot of Stuff in the Pipeline”
Fundamentals & Data ▾
Pfizer Inc. Healthcare · Drug Manufacturers - General
Mkt Cap
$153B
P/E
19.8 fwd 9.6
Beta
0.39
Div Yield
639.00%
52w Range
$21.87 - $28.75
Short Interest
132.5M 2.33%
Days to Cover
3.2 -7%
Technicals downtrend
from 52w Hi
-4.3%
1w return
+0.0%
Insiders
mixed 2B / 2S
Analysts
mixed
EPS Estimate
$0.72 -1.5% 30d 3up / 2dn
Est. Dispersion
26% 18 analysts
Analyst Target
$29 $25 - $36
Options P/C
0.24
Insider Cluster
buy cluster 2B / 1S
Fund Convergence
strong D.E. Shaw, Citadel, Two Sigma
Financials
Revenue
$17.6B -1% YoY
FCF
$4.5B
Gross Margin
70%
Op Margin
21%
Momentum: decelerating
Top Holders
D.E. Shaw $1.3B
Citadel $855M
Point72 $153M
Two Sigma
Recent Filings & Data
insider trade 29
net buying · $212,539 sold · $527,312 bought
10 insiders · 29 transactions (30d)
Recent transactions
DAMICO JENNIFER B. · sell · $147,714
DAMICO JENNIFER B. · award
FONSECA LIDIA PH.D. · exercise · $1,923,952
LANKLER DOUGLAS M · exercise · $4,156,715
DAMICO JENNIFER B. · exercise · $593,812
SAHNI PAYAL · exercise · $1,923,952
MCDERMOTT MICHAEL · exercise · $1,282,624
BOSHOFF CHRISTOFFEL · award
BOURLA ALBERT · exercise · $16,626,791
DAMICO JENNIFER B. · award
DAMICO JENNIFER B. · sell · $64,825
FONSECA LIDIA PH.D. · exercise · $2,274,014
LANKLER DOUGLAS M · exercise · $4,912,977
SUSMAN SALLY · exercise · $2,667,048
DAMICO JENNIFER B. · exercise · $701,845
SAHNI PAYAL · exercise · $596,581
MCDERMOTT MICHAEL · exercise · $1,515,999
BOSHOFF CHRISTOFFEL · award
BOURLA ALBERT · exercise · $18,248,188
BOSHOFF CHRISTOFFEL · award
LANKLER DOUGLAS M · exercise · $2,589,310
SUSMAN SALLY · exercise · $1,917,997
DAMICO JENNIFER B. · exercise · $263,716
SAHNI PAYAL · exercise · $383,581
MCDERMOTT MICHAEL · exercise · $335,641
BOSHOFF CHRISTOFFEL · exercise · $263,716
BOURLA ALBERT · exercise · $7,192,498
BLAYLOCK RONALD E · buy · $499,072
GOTTLIEB SCOTT · buy · $28,240
ⓘ Filing analysis pending — next scan runs every 12 hours
ⓘ Transcript analysis coming soon
15 signals · latest 1d ago

Get alerted when PFE changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →